Cargando…

Corrigendum to “A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination” [Virology 566 (2022) 56–59]

Detalles Bibliográficos
Autores principales: Hu, Zhidong, Chen, Jian-Ping, Xu, Jin-Chuan, Chen, Zhen-Yan, Qu, Rong, Zhang, Ling, Yao, Wenrong, Wu, Juan, Yang, Heng, Lowrie, Douglas B., Liu, Yong, Fan, Xiao-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701553/
https://www.ncbi.nlm.nih.gov/pubmed/36442339
http://dx.doi.org/10.1016/j.virol.2022.11.007
_version_ 1784839558955794432
author Hu, Zhidong
Chen, Jian-Ping
Xu, Jin-Chuan
Chen, Zhen-Yan
Qu, Rong
Zhang, Ling
Yao, Wenrong
Wu, Juan
Yang, Heng
Lowrie, Douglas B.
Liu, Yong
Fan, Xiao-Yong
author_facet Hu, Zhidong
Chen, Jian-Ping
Xu, Jin-Chuan
Chen, Zhen-Yan
Qu, Rong
Zhang, Ling
Yao, Wenrong
Wu, Juan
Yang, Heng
Lowrie, Douglas B.
Liu, Yong
Fan, Xiao-Yong
author_sort Hu, Zhidong
collection PubMed
description
format Online
Article
Text
id pubmed-9701553
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-97015532022-11-28 Corrigendum to “A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination” [Virology 566 (2022) 56–59] Hu, Zhidong Chen, Jian-Ping Xu, Jin-Chuan Chen, Zhen-Yan Qu, Rong Zhang, Ling Yao, Wenrong Wu, Juan Yang, Heng Lowrie, Douglas B. Liu, Yong Fan, Xiao-Yong Virology Corrigendum Published by Elsevier Inc. 2023-01 2022-11-26 /pmc/articles/PMC9701553/ /pubmed/36442339 http://dx.doi.org/10.1016/j.virol.2022.11.007 Text en © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Corrigendum
Hu, Zhidong
Chen, Jian-Ping
Xu, Jin-Chuan
Chen, Zhen-Yan
Qu, Rong
Zhang, Ling
Yao, Wenrong
Wu, Juan
Yang, Heng
Lowrie, Douglas B.
Liu, Yong
Fan, Xiao-Yong
Corrigendum to “A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination” [Virology 566 (2022) 56–59]
title Corrigendum to “A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination” [Virology 566 (2022) 56–59]
title_full Corrigendum to “A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination” [Virology 566 (2022) 56–59]
title_fullStr Corrigendum to “A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination” [Virology 566 (2022) 56–59]
title_full_unstemmed Corrigendum to “A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination” [Virology 566 (2022) 56–59]
title_short Corrigendum to “A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination” [Virology 566 (2022) 56–59]
title_sort corrigendum to “a two-dose optimum for recombinant s1 protein-based covid-19 vaccination” [virology 566 (2022) 56–59]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701553/
https://www.ncbi.nlm.nih.gov/pubmed/36442339
http://dx.doi.org/10.1016/j.virol.2022.11.007
work_keys_str_mv AT huzhidong corrigendumtoatwodoseoptimumforrecombinants1proteinbasedcovid19vaccinationvirology56620225659
AT chenjianping corrigendumtoatwodoseoptimumforrecombinants1proteinbasedcovid19vaccinationvirology56620225659
AT xujinchuan corrigendumtoatwodoseoptimumforrecombinants1proteinbasedcovid19vaccinationvirology56620225659
AT chenzhenyan corrigendumtoatwodoseoptimumforrecombinants1proteinbasedcovid19vaccinationvirology56620225659
AT qurong corrigendumtoatwodoseoptimumforrecombinants1proteinbasedcovid19vaccinationvirology56620225659
AT zhangling corrigendumtoatwodoseoptimumforrecombinants1proteinbasedcovid19vaccinationvirology56620225659
AT yaowenrong corrigendumtoatwodoseoptimumforrecombinants1proteinbasedcovid19vaccinationvirology56620225659
AT wujuan corrigendumtoatwodoseoptimumforrecombinants1proteinbasedcovid19vaccinationvirology56620225659
AT yangheng corrigendumtoatwodoseoptimumforrecombinants1proteinbasedcovid19vaccinationvirology56620225659
AT lowriedouglasb corrigendumtoatwodoseoptimumforrecombinants1proteinbasedcovid19vaccinationvirology56620225659
AT liuyong corrigendumtoatwodoseoptimumforrecombinants1proteinbasedcovid19vaccinationvirology56620225659
AT fanxiaoyong corrigendumtoatwodoseoptimumforrecombinants1proteinbasedcovid19vaccinationvirology56620225659